Report Scope & Overview:
The Bone Densitometer Market Size was valued at USD 42.90 billion in 2022, and is expected to reach USD 78.24 billion by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
An instrument called a bone densitometer is used to evaluate the density and mineral content of bones. To do this, X-rays and dual-energy X-ray absorptiometry can be utilised (DEXA or DXA). The simple and non-invasive DEXA scan is the gold standard in this field. This evaluation reveals whether a patient's bone mass is declining. Bone fractures and breaks are more prone to occur as a result of this illness. To evaluate whether a person has osteopenia or osteoporosis, a bone densitometer is employed. The likelihood of upcoming fractures is also predicted using it.
To get more information on Bone Densitometer Market - Request Sample Report
The International Osteoporosis Federation states that dual-energy X-ray absorptiometry instruments will be accessible for the diagnosis of osteoporosis disease. The rising use of bone densitometers, which is anticipated to boost market growth, is a result of the increase in the prevalence of osteoporosis illnesses. Additionally, it is anticipated that the number of product approvals would increase throughout the forecasted period, providing attractive opportunities for the global Bone Densitometer Market to expand.
Osteoporosis is progressing at a rise
Raise in the population of geriatrics
Decline in kidney disease prevalence
Very expensive bone densitometry
More opportunities in new market.
Budget cuts for hospitals
Access to diagnostics is insufficient
Reimbursement scenario that is not favorable
IMPACT OF COVID-19
Over the years, the COVID-19 sickness wreaked enormous damage. Companies in the biotechnology and pharmaceutical industries suffered significantly. Numerous markets were shut down around the world as a result of the lockdown and restrictions on movement. The supply chain was severely disrupted as a result. Various businesses also suffered financial damages. However, it is projected that the Bone Densitometers Market would resume its rise due to the considerable development and investments made by the leading players. Additionally, during the examined projected period, favourable drivers are fueling market expansion.
The Bone Densitometers Market is segmented into three categories: technology, application, and end-user. In the bone densitometer market, the axial bone densitometry sector was dominant. It is anticipated that the category will develop due to the advantages of DEXA scanners over peripheral bone densitometers and their higher accuracy.
The global market for bone densitometers was dominated by osteoporosis and osteopenia diagnoses, and this segment is anticipated to increase at the greatest CAGR. The expansion of this market segment is being driven by an ageing population and the concomitant rise in osteoporosis prevalence.
The sector of the market for bone densitometers that included hospitals and specialist clinics held the biggest market share. The vast majority of bone density scans are carried out in hospitals as a result of the patients' choice for hospital-based therapy monitoring of conditions such cystic fibrosis, chronic renal disease, and osteoporosis, which is fueling the segment's expansion.
KEY MARKET SEGMENTS:
Axial Bone Densitometry
Dual energy x-ray absorptiometry (DEXA)
Quantitative computed tomography (QCT)
Peripheral Bone Densitometry
Quantitative ultrasound (QUS)
Radiographic Absorptiometry (RA)
Osteoporosis and osteopenia diagnosis
Cystic fibrosis diagnosis
Chronic kidney diseases diagnosis
Body composition measurement diagnosis
Rheumatoid arthritis diagnosis
By End User
Hospitals & specialty clinics
Diagnostic & imaging centers
Need any customization research on Bone Densitometer Market - Enquiry Now
Due to the presence of key players, the growth of the healthcare industry, and the introduction of new bone densitometer products in the region, North America commanded the largest market share for bone densitometers and is anticipated to continue to hold this position throughout the forecast period. However, due to the predominance of the senior population, which has increased the number of bone fracture cases, and the development of the healthcare infrastructure, Asia-Pacific is predicted to see the highest CAGR from 2023 to 2030.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company, Osteometer MediTech Inc., Hologic Inc., Swissray International Inc., Medilink. and Other Players
|Market Size in 2022||US$ 42.90 Billion|
|Market Size by 2030||US$ 78.24 Billion|
|CAGR||CAGR of 7.8% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Technology (Axial Bone Densitometry, Dual energy x-ray absorptiometry (DEXA), Quantitative computed tomography (QCT), Peripheral Bone Densitometry, Quantitative ultrasound (QUS), Radiographic Absorptiometry (RA))
• By Application (Osteoporosis and osteopenia diagnosis, Cystic fibrosis diagnosis, Chronic kidney diseases diagnosis, Body composition measurement diagnosis, Rheumatoid arthritis diagnosis)
• By End User (Hospitals & specialty clinics, Diagnostic & imaging centers)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company, Osteometer MediTech Inc., Hologic Inc., Swissray International Inc., Medilink.|
|Key Drivers||• Osteoporosis is progressing at a rise
• Raise in the population of geriatrics
|RESTRAINTS||• Very expensive bone densitometry|
Ans: The Bone densitometer Market size was valued at US$ 42.90 billion in 2022.
Ans. The Bone densitometer Market is to grow at a CAGR of 7.8% over the forecast period 2023-2030.
Ans. Key drivers of the Bone densitometer Market is Raise in the population of geriatrics, and decline in kidney disease prevalence
Ans. DMS Imaging, BeamMed Ltd., Ecolight S.P.A., Demetech AB., Medonica Co. Ltd, General Electric Company are the key plyer of Bone densitometer Market.
Ans. Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, Fundamental Research.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
188.8.131.52 United Kingdom
184.108.40.206 South Korea
220.127.116.11 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Bone densitometer Market Segmentation, By Technology
8.1 Axial Bone Densitometry
8.2 Dual energy x-ray absorptiometry (DEXA)
8.3 Quantitative computed tomography (QCT)
8.4 Peripheral Bone Densitometry
8.5 Quantitative ultrasound (QUS)
8.6 Radiographic Absorptiometry (RA)
9. Bone densitometer Market Segmentation, By Application
9.1 Osteoporosis and osteopenia diagnosis
9.2 Cystic fibrosis diagnosis
9.3 chronic kidney diseases diagnosis
9.4 Body composition measurement diagnosis
9.5 Rheumatoid arthritis diagnosis
10. Bone densitometer Market Segmentation, By End User
10.1 Hospitals & specialty clinics
10.2 Diagnostic & imaging centers
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12. Company Profiles
12.1 DMS Imaging
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 BeamMed Ltd.
12.3 Ecolight S.P.A.
12.4 Demetech AB.
12.5 Medonica Co. Ltd
12.6 General Electric Company
12.7 Osteometer MediTech Inc.
12.8 Hologic Inc.
12.9 Swissray International Inc.
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Pressure ulcer treatment market size was estimated USD 5.6 billion in 2022 and is expected to reach USD 9.47 billion by 2030 at a CAGR of 6.8% during the forecast period of 2023-2030.
The Dual Chamber Prefilled Syringes Market size was USD 154.21 million in 2022 and is expected to Reach USD 268.56 million by 2030 and grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
The Foot Orthotic Insoles Market size was valued at USD 3.42 Billion in 2022 and is expected to reach USD 5.87 Billion By 2030 and grow at a CAGR of 7% over the forecast period of 2023-2030.
The Healthcare Information Technology Market Size was valued at USD 177.02 billion in 2022, and is expected to reach USD 1400 billion by 2030 and grow at a CAGR of 29.5% over the forecast period 2023-2030.
The Single-use Bioprocessing Market size was estimated USD 9.1 billion in 2022 and is expected to reach USD 41.5 billion by 2030 at a CAGR of 20.9% during the forecast period of 2023-2030.
The Healthcare IT Outsourcing Market Size was valued at USD 68.86 billion in 2022, and is expected to reach USD 118.40 billion by 2030 and grow at a CAGR of 7.01% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone